Evaluating PFAS Human Health Hazard Data Availability: EPA Assessment Portfolio and Evidence Maps
On this page:
Over the last several decades, public health agencies at the state and federal level, including the United States Environmental Protection Agency (EPA), Food and Drug Administration (FDA), and Agency for Toxic Substances and Disease Registry (ATSDR) have worked to understand and reduce the environmental and human health effects of per- and polyfluoroalkyl substances (PFAS). A session titled "Federal and State Approaches for Addressing Exposure of Per- and Polyfluoroalkyl Substances (PFAS)" at the 2023 Toxicology and Risk Assessment Conference will provide an opportunity for representatives from federal and state agencies to present ongoing efforts to address exposure and evaluate health effects to a wide range of PFAS and engage in a discussion on how to overcome current specific challenges associated with PFAS exposure and health risk assessments.